Cargando…
Association between response to triptans and response to erenumab: real-life data
BACKGROUND: Triptans and erenumab are both migraine-specific agents acting on the calcitonin gene-related peptide pathway. Therefore, response to triptans might be associated with response to erenumab. MAIN BODY: In our study, consecutive patients referring to the Headache Centers of the Abruzzo reg...
Autores principales: | Frattale, Ilaria, Caponnetto, Valeria, Casalena, Alfonsina, Assetta, Maurizio, Maddestra, Maurizio, Marzoli, Fabio, Affaitati, Giannapia, Giamberardino, Maria Adele, Viola, Stefano, Gabriele, Amleto, Pistoia, Francesca, Cerone, Davide, Marini, Carmine, Sacco, Simona, Ornello, Raffaele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789681/ https://www.ncbi.nlm.nih.gov/pubmed/33407070 http://dx.doi.org/10.1186/s10194-020-01213-3 |
Ejemplares similares
-
Real-life data on the efficacy and safety of erenumab in the Abruzzo region, central Italy
por: Ornello, Raffaele, et al.
Publicado: (2020) -
Conversion from chronic to episodic migraine in patients treated with erenumab: real-life data from an Italian region
por: Ornello, Raffaele, et al.
Publicado: (2020) -
Cranial autonomic symptoms and response to monoclonal antibodies targeting the Calcitonin gene-related peptide pathway: A real-world study
por: De Matteis, Eleonora, et al.
Publicado: (2022) -
Menstrual Headache in Women with Chronic Migraine Treated with Erenumab: An Observational Case Series
por: Ornello, Raffaele, et al.
Publicado: (2021) -
Gender Differences in 3-Month Outcomes of Erenumab Treatment—Study on Efficacy and Safety of Treatment With Erenumab in Men
por: Ornello, Raffaele, et al.
Publicado: (2021)